February 27, 2018 / 6:06 AM / 6 months ago

BRIEF-Hungary's Richter cuts long-term Esmya sales targets

Feb 27 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt :

* HAS LOWERED LONG-TERM SALES TARGETS FOR UTERINE FIBROID MEDICINE ESMYA FOR EUROPEAN UNION AND LATIN AMERICAN MARKETS

* TO ACCOUNT FOR AN IMPAIRMENT LOSS OF ABOUT 42 BILLION FORINTS ($165.22 MILLION) WITH REGARD TO INTANGIBLE ASSET AND GOODWILL LINKED TO ESMYA

* 2017 OPERATING AND NET PROFIT WILL “SIGNIFICANTLY FALL BEHIND” AMOUNTS PUBLISHED ON FEB. 12 Further company coverage: ($1 = 254.21 forints) (Reporting by Gergely Szakacs)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below